HomeELGIEQUIP › Filing
🔔 Get instant alerts when ELGIEQUIP files quarterly results on BSE Start free trial →

Transcript

Filed: 20 Aug 2026, 15:45 IST Exchange: BSE Category: Financial Results — Earnings Call Transcript
AI summary - Q1FY27 revenue grew 23% y-y; EBITDA up 28%, EBITDA margin stable y-y - India revenue grew 28%, North America 37%, Europe 21%, Australia 17% - Raw material costs rose 5-6%, price hikes to fully reflect by Q3FY27 - Demand=Match technology launched in India, global rollout ongoing in 2026 - Aftermarket revenue ~30% in India, ~16% globally; strong growth supports margins - Capex focused on new campus and land in Italy; net cash position strong - Growth in EV ecosystem, renewables, semiconductor sectors noted but currently small - Margin improvement driven by cost reduction, reorganization, motor insourcing - Target EBITDA margin 20% by 2031; ongoing process improvements to drive efficiency
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ELGIEQUIP — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ELGIEQUIP to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Elgi Equipments Limited

Important. The summary above is generated automatically from Elgi Equipments Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.